Sharing data from clinical trials can produce new insights, establish credibility and honor the contributions of participating patients if researchers answer questions about what gets shared and change attitudes by addressing concerns about how to share responsibly, writes Frank Rockhold, PhD, professor of Biostatistics and Bioinformatics, in For The Record magazine.
Frank Rockhold, PhD, professor of biostatistics and bioinformatics, has been a leading biostatistician in the pharmaceutical industry with more than 30 years of diverse experience in clinical trial design, data monitoring, decision sciences, statistical research, and epidemiology. He joined the Biostatistics Department earlier this year. Rockhold was most recently senior vice president of Global Clinical Safety and Pharmacovigilance at GlaxoSmithKline.